María Jaramillo

1.8k total citations
41 papers, 1.5k citations indexed

About

María Jaramillo is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, María Jaramillo has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in María Jaramillo's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and RNA Research and Splicing (6 papers). María Jaramillo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and RNA Research and Splicing (6 papers). María Jaramillo collaborates with scholars based in Canada, United States and Spain. María Jaramillo's co-authors include Maureen D. O'Connor‐McCourt, Nahum Sonenberg, John C. Bell, Enrico O. Purisima, Edwin Wang, M. Banville, Liu Yl, Catherine Collins, Qinghua Cui and Lu Meng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

María Jaramillo

41 papers receiving 1.4k citations

Peers

María Jaramillo

ONCOL

RNMI

IMMUN

Bhavneet Bhinder United States

Deborah Wilsker United States

Dieter Moosmayer Germany

Damaris Bausch‐Fluck Switzerland

Erik Björling Sweden

Violette Paragas United States

Ingrid Remy Canada

Clarence Yapp United States

Ralph Schiess Switzerland

Mohammad Fallahi‐Sichani United States

Bhavneet Bhinder United States

María Jaramillo

891 ×0.9

333 ×1.1

ONCOL

233 ×0.9

RNMI

199 ×1.0

IMMUN

415 ×2.8

Citations per year, relative to María Jaramillo María Jaramillo (= 1×) peers Bhavneet Bhinder

Countries citing papers authored by María Jaramillo

Since Specialization

Citations

This map shows the geographic impact of María Jaramillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Jaramillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Jaramillo more than expected).

Fields of papers citing papers by María Jaramillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Jaramillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Jaramillo. The network helps show where María Jaramillo may publish in the future.

Co-authorship network of co-authors of María Jaramillo

This figure shows the co-authorship network connecting the top 25 collaborators of María Jaramillo. A scholar is included among the top collaborators of María Jaramillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Jaramillo. María Jaramillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabariès, Sébastien, Anne Marcil, Binbing Ling, et al.. (2024). Anti-Claudin-2 Antibody–Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis. Molecular Cancer Therapeutics. 23(10). 1459–1470. 3 indexed citations

Henry, Kevin A., Toya Nath Baral, Greg Hussack, et al.. (2021). Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement. Biochemical and Biophysical Research Communications. 562. 154–161. 8 indexed citations

Sulea, Traian, Nazanin Rohani, Jason Baardsnes, et al.. (2019). Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment. mAbs. 12(1). 1682866–1682866. 61 indexed citations

Zwaagstra, John C., et al.. (2019). Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates. PLoS ONE. 14(12). e0226593–e0226593. 11 indexed citations

Baardsnes, Jason, Christophe Deprez, Traian Sulea, et al.. (2017). Assisted Design of Antibody and Protein Therapeutics (ADAPT). PLoS ONE. 12(7). e0181490–e0181490. 36 indexed citations

Mukundan, Shilpaa, et al.. (2016). Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression. Cancer Research. 76(13). 3732–3743. 61 indexed citations

Sarmiento, E., María Jaramillo, J. Fernàndez-Yáñez, et al.. (2016). Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study. The Journal of Heart and Lung Transplantation. 36(5). 529–539. 32 indexed citations

Cruz‐Muñoz, William, Teresa Di Desidero, Shan Man, et al.. (2014). Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer. Angiogenesis. 17(3). 661–73. 17 indexed citations

Zaman, Naif, Lei Li, María Jaramillo, et al.. (2013). Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets. Cell Reports. 5(1). 216–223. 92 indexed citations

10.

Cruz‐Muñoz, William, María Jaramillo, Shan Man, et al.. (2012). Roles for Endothelin Receptor B and BCL2A1 in Spontaneous CNS Metastasis of Melanoma. Cancer Research. 72(19). 4909–4919. 49 indexed citations

11.

Jaramillo, María, et al.. (2012). Population Based Model of Human Embryonic Stem Cell (hESC) Differentiation during Endoderm Induction. PLoS ONE. 7(3). e32975–e32975. 10 indexed citations

12.

Bell, Andrea M., Mehdi Arbabi‐Ghahroudi, Yves Durocher, et al.. (2009). Differential tumor-targeting abilities of three single-domain antibody formats. Cancer Letters. 289(1). 81–90. 93 indexed citations

13.

Jaramillo, María, et al.. (2008). Differential sensitivity of A549 non small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors. Cancer Biology & Therapy. 7(4). 557–568. 29 indexed citations

14.

Zou, Li, et al.. (2007). Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. British Journal of Cancer. 97(10). 1361–1371. 90 indexed citations

15.

Ogorelkova, M., John C. Zwaagstra, Seyyed Mehdy Elahi, et al.. (2006). Adenovirus-Delivered Antisense RNA and shRNA Exhibit Different Silencing Efficiencies for the Endogenous Transforming Growth Factor- β (TGF- β ) Type II Receptor. Oligonucleotides. 16(1). 2–14. 4 indexed citations

16.

Jaramillo, María, et al.. (2006). Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. Experimental Cell Research. 312(15). 2778–2790. 77 indexed citations

17.

Jaramillo, María, et al.. (2004). Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice. Biologicals. 32(3). 157–163. 15 indexed citations

18.

Yu, Zhenbao, et al.. (1998). SHP-1 Associates with Both Platelet-derived Growth Factor Receptor and the p85 Subunit of Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry. 273(6). 3687–3694. 80 indexed citations

19.

Jaramillo, María, N. B. Abraham, & John C. Bell. (1995). Molecular Biology: The Interferon System: A Review with Emphasis on the Role of PKR in Growth Control. Cancer Investigation. 13(3). 327–338. 35 indexed citations

20.

Cone, Roger D., Terri Grodzicker, & María Jaramillo. (1988). A retrovirus Expressing the 12S Adenoviral E1A Gene Product Can Immortalize Epithelial Cells from a Broad Range of Rat Tissues. Molecular and Cellular Biology. 8(3). 1036–1044. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact